SCHEMBL16010027

SCHEMBL16010027

C#CCc1ccc2c(c1CC#C)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 10/20 0.51
MAPT P10636 3/20 0.51
HPGD P15428 2/20 0.51
MEN1 O00255 2/20 0.51
HTT P42858 2/20 0.51
KMT2A Q03164 2/20 0.51
CYP2C19 P33261 1/20 0.51
RECQL P46063 1/20 0.51
BLM P54132 1/20 0.51
SMAD3 P84022 1/20 0.51
PRMT1 Q99873 1/20 0.51
ACE2 Q9BYF1 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
ALDH1A1 P00352 2/20 0.49
ALOX12 P18054 2/20 0.49
CYP2C9 P11712 1/20 0.49
ALOX15 P16050 1/20 0.49
BRCA1 P38398 1/20 0.49
HSD17B10 Q99714 1/20 0.49
LMNA P02545 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16010080 0.87 FTO (0.55) FTOMAPTHPGDMEN1HTT
SCHEMBL17079673 0.81 FTO (0.55) FTOMAPTHPGDMEN1HTT
SCHEMBL4941647 0.78 FTO (0.52) FTOMAPTHPGDMEN1HTT
SCHEMBL239423 0.77 HPGD (0.55) FTOMAPTHPGDMEN1HTT
SCHEMBL5475534 0.77 FTO (0.63) FTOMAPTHPGDMEN1HTT
SCHEMBL19206099 0.76 FTO (0.50) FTOMAPTHPGDMEN1HTT
SCHEMBL3485942 0.76 HPGD (0.50) FTOMAPTHPGDMEN1HTT
SCHEMBL5431416 0.75 FTO (0.57) FTOMAPTHPGDMEN1HTT
SCHEMBL4743773 0.75 FTO (0.60) FTOMAPTHPGDMEN1HTT
SCHEMBL2314510 0.75 FTO (0.60) FTOMAPTHPGDMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256015-A1 CAGED COMPOUND WHICH CAN BE PHOTOACTIVATED SELECTIVELY FOR CELL TYPES TOHO UNIVERSITY (JP) 2014-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256015-A1 CAGED COMPOUND WHICH CAN BE PHOTOACTIVATED SELECTIVELY FOR CELL TYPES CTSK, CTSF, TPX2 FTO 191/4885MAPT 4798/4885HPGD 1443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.